Back to search

Netherlands· NL-b232ef4771aa

Clinimix N9 G15 E, oplossing voor infusie

A lösungen zur parenteralen ernährung, kombinationen product containing acetaat (c2h3o2-) + alanine, (l-) + arginine, (l-) + calcium (ca2+), registered in Netherlands by Baxter B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC B05BA10

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedClinimix N9 G15 E, oplossing voor inf…ATCB05BA10REGISTER NO.NL-b232ef4771aaPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Lösungen zur parenteralen ernährung, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC B05BA10 (lösungen zur parenteralen ernährung, kombinationen), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Lösungen zur parenteralen ernährung, kombinationen · ATC B05BA10

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ACETAAT (C2H3O2-) + ALANINE, (L-) + ARGININE, (L-) + CALCIUM (Ca2+)
Manufacturer
Baxter B.V.
Country
Netherlands (NL)
ATC code
B05BA10
ATC class
Lösungen zur parenteralen Ernährung, Kombinationen
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    17375

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

6 interactions on record for lösungen zur parenteralen ernährung, kombinationen.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lösungen zur parenteralen ernährung, kombinationen · interactions on record

6 records

  • 2 severe
  • 4 moderate

Most severe, free to view

  • ErdafitinibL01EN01severe
  • ErdafitinibL01EX16severe
  • AmfetamineN06BA01moderate
  • DexamfetamineN06BA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c523969e-36ca-408c-9f16-6d294b1226d0
GET /v1/drugs/c523969e-36ca-408c-9f16-6d294b1226d0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h17375_smpc.pdf",
  "strength": null,
  "atc_label": "Combinations",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg17375",
  "excipients": [
    "AZIJNZUUR (E 260), GECONCENTREERD",
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "ACETAAT  (C2H3O2-)",
    "ALANINE, (L-)",
    "ARGININE, (L-)",
    "CALCIUM (Ca2+)",
    "CALCIUMCHLORIDE 2-WATER (E 509)",
    "CHLORIDE (CL-)",
    "DIKALIUMWATERSTOFFOSFAAT 0-WATER (E 340)",
    "FENYLALANINE, (L-)",
    "GLUCOSE 0-WATER",
    "GLYCINE (E 640)",
    "HISTIDINE, (L-)",
    "HYDROGENOPHOSPHAS (LN)",
    "ISOLEUCINE, (L-)",
    "KALIUM (K+)",
    "LEUCINE, (L-) (E 641)",
    "LYSINEHYDROCHLORIDE, L-",
    "MAGNESIUM (MG2+)",
    "MAGNESIUMCHLORIDE 6-WATER (E 511)",
    "METHIONINE, (L-)",
    "NATRIUM (NA+)",
    "NATRIUMACETAAT 3-WATER (E 262)",
    "NATRIUMCHLORIDE",
    "PROLINE, (L-)",
    "SERINE, (L-)",
    "THREONINE, (L-)",
    "TRYPTOFAAN, (L-)",
    "TYROSINE, (L-)",
    "VALINE, (L-)"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h17375.pdf",
  "authorised_at": "1998/03/30",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "17375",
  "additional_monitoring": "N"
}

See everything about lösungen zur parenteralen ernährung, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.